(Total Views: 603)
Posted On: 03/05/2021 7:38:41 PM
Post# of 145875
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Re: penniestodimes #80962
penniestodimes,
Tocilizumab EUA in UK based on 4% reduction in mortality (11% relative reduction).
However, that was a large trial. There is a very real possibility that an expanded trial will be required.
The upside is that with these good results it should be much easier to enroll than previously.
Tocilizumab EUA in UK based on 4% reduction in mortality (11% relative reduction).
However, that was a large trial. There is a very real possibility that an expanded trial will be required.
The upside is that with these good results it should be much easier to enroll than previously.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)